Literature DB >> 23739104

Epilepsy and neuropsychological comorbidities.

Leslie A Rudzinski1, Kimford J Meador.   

Abstract

PURPOSE OF REVIEW: Epilepsy is a chronic disorder with several associated comorbidities requiring timely recognition and treatment. This article discusses aspects of cognitive impairment; psychiatric disorders including depression, anxiety, and psychosis; and health-related quality-of-life issues pertaining to patients with epilepsy. RECENT
FINDINGS: Cognitive problems in epilepsy may be present early in the disease course. Advances in imaging techniques are allowing correlation of structure and function as they relate to cognitive impairment in epilepsy. The relationship between epilepsy, depression, and anxiety is increasingly recognized, and these psychiatric comorbidities may affect suicide risk, patient-reported adverse antiepileptic drug effects, and quality of life. Psychiatric disorders are underrecognized and undertreated in patients with epilepsy.
SUMMARY: Physicians who treat patients with epilepsy should be aware of the major impact that cognitive impairment and psychiatric comorbidities have on these patients. Identifying and treating these comorbidities in epilepsy patients is just as important as seizure treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739104     DOI: 10.1212/01.CON.0000431382.06438.cd

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  9 in total

1.  Cognitive Outcome in Childhood-Onset Epilepsy: A Five-Decade Prospective Cohort Study.

Authors:  Mira Karrasch; Petri Tiitta; Bruce Hermann; Juho Joutsa; Shlomo Shinnar; Juha Rinne; Anu Anttinen; Matti Sillanpää
Journal:  J Int Neuropsychol Soc       Date:  2017-01-10       Impact factor: 2.892

2.  Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial.

Authors:  Nicholas A Streltzov; Samantha S Schmidt; Lindsay M Schommer; Wenyan Zhao; Tor D Tosteson; Morgan T Mazanec; Elaine T Kiriakopoulos; Felicia Chu; Heidi L Henninger; Keith Nagle; Robert M Roth; Barbara Jobst
Journal:  Neurology       Date:  2022-04-06       Impact factor: 11.800

3.  Glycine transporter 1 is a target for the treatment of epilepsy.

Authors:  Hai-Ying Shen; Erwin A van Vliet; Kerry-Ann Bright; Marissa Hanthorn; Nikki K Lytle; Jan Gorter; Eleonora Aronica; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

4.  Family functioning, marital quality and social support in Chinese patients with epilepsy.

Authors:  Yi-he Wang; Michelle Haslam; Ming Yu; Juan Ding; Qian Lu; Fang Pan
Journal:  Health Qual Life Outcomes       Date:  2015-01-28       Impact factor: 3.186

5.  Behavioral Abnormalities in Lagotto Romagnolo Dogs with a History of Benign Familial Juvenile Epilepsy: A Long-Term Follow-Up Study.

Authors:  T S Jokinen; K Tiira; L Metsähonkala; E H Seppälä; A Hielm-Björkman; H Lohi; O Laitinen-Vapaavuori
Journal:  J Vet Intern Med       Date:  2015-05-06       Impact factor: 3.333

6.  Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.

Authors:  Kimford J Meador; Haichen Yang; Jesus Eric Piña-Garza; Antonio Laurenza; Dinesh Kumar; Keith A Wesnes
Journal:  Epilepsia       Date:  2016-01-01       Impact factor: 5.864

7.  Influence of Marital Status on the Quality of Life of Chinese Adult Patients with Epilepsy.

Authors:  Fu-Li Wang; Xiang-Min Gu; Bao-Yun Hao; Shan Wang; Ze-Jie Chen; Cheng-Yun Ding
Journal:  Chin Med J (Engl)       Date:  2017 5th Jan 2017       Impact factor: 2.628

8.  Network, clinical and sociodemographic features of cognitive phenotypes in temporal lobe epilepsy.

Authors:  Bruce Hermann; Lisa L Conant; Cole J Cook; Gyujoon Hwang; Camille Garcia-Ramos; Kevin Dabbs; Veena A Nair; Jedidiah Mathis; Charlene N Rivera Bonet; Linda Allen; Dace N Almane; Karina Arkush; Rasmus Birn; Edgar A DeYoe; Elizabeth Felton; Rama Maganti; Andrew Nencka; Manoj Raghavan; Umang Shah; Veronica N Sosa; Aaron F Struck; Candida Ustine; Anny Reyes; Erik Kaestner; Carrie McDonald; Vivek Prabhakaran; Jeffrey R Binder; Mary E Meyerand
Journal:  Neuroimage Clin       Date:  2020-07-10       Impact factor: 4.881

9.  A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.

Authors:  Kingsley Ibhazehiebo; Cezar Gavrilovici; Cristiane L de la Hoz; Shun-Chieh Ma; Renata Rehak; Gaurav Kaushik; Paola L Meza Santoscoy; Lucas Scott; Nandan Nath; Do-Young Kim; Jong M Rho; Deborah M Kurrasch
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.